RPGLIFE vs SAILIFE: Stock Comparison

RPG Life Sciences Limited vs Sai Life Sciences Limited

Live data: 22 July 2026, 3:06 PM IST • Source: NSE and company filings

Sai Life Sciences Limited is the larger company by market capitalisation. RPG Life Sciences Limited shows a lower P/E, a higher ROE and a higher dividend yield. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.

Side-by-side comparison of RPG Life Sciences Limited and Sai Life Sciences Limited on live price, valuation, growth, profitability, leverage and quarterly shareholding. Highlighted values mark the more favourable of the two on that metric's usual reading; a single metric is never the full story.

On standard readings, RPGLIFE is more favourable on 11 of 13 scored metrics and SAILIFE on 2These counts are context-free and are not an overall rating.

Key Differences

Market Cap
SAILIFE is the larger company
₹26,504 Cr vs ₹4,976 Cr
P/E Ratio
RPGLIFE has a lower P/E
43.37x vs 78.57x
P/B Ratio
RPGLIFE has a lower P/B
8.25x vs 11.04x
EPS
RPGLIFE has higher earnings per share
₹69.65 vs ₹16.43
Dividend Yield
RPGLIFE has a higher dividend yield
0.75% vs 0%
Revenue Growth (TTM YoY)
RPGLIFE has faster revenue growth
23.6% vs 3.9%
EPS Growth (TTM YoY)
SAILIFE has faster EPS growth
17.6% vs -74.5%
Qtr Sales Growth
RPGLIFE has stronger quarterly sales growth
23.6% vs 3.91%

Each difference is a single, relative reading — StockeZee does not name an overall winner.

Profile

MetricRPGLIFESAILIFE
SectorHealthcareHealthcare
IndustryPharmaceuticalsPharmaceuticals

Price

MetricRPGLIFESAILIFE
Live Price₹3,014₹1,250.6
Day Change0.54%-2.96%
Volume30,6003.68 L
52-Week High₹3,082₹1,300
52-Week Low₹1,733₹778.5
Distance from 52W High-2.21%-3.8%

Valuation

MetricRPGLIFESAILIFE
Market Cap₹4,976 Cr₹26,504 Cr
P/E Ratio43.37x78.57x
P/B Ratio8.25x11.04x
EPS₹69.65₹16.43
Book Value₹366.04₹117.47
Dividend Yield0.75%0%

Growth

MetricRPGLIFESAILIFE
Revenue Growth (TTM YoY)23.6%3.9%
EPS Growth (TTM YoY)-74.5%17.6%
Qtr Sales Growth23.6%3.91%
Qtr Profit Growth33.7%17.8%

Profitability & Leverage

MetricRPGLIFESAILIFE
ROE19.3%15.4%
ROCE25.7%19.6%
Net Margin29.25%15.81%
Operating Margin20.9%28.8%
Debt to Equity0.03x0.12x

Shareholding

As of Mar 2026 • change vs previous quarter
MetricRPGLIFESAILIFE
Promoter Holding72.95%32.95% 0.08 pp
FII Holding0.87% 0.13 pp21.17% 0.23 pp
DII Holding7.45% 0.41 pp31.54% 0.13 pp
Public Holding18.73% 0.28 pp12.68% 0.19 pp

How to Read This Comparison

Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.

Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: RPG Life Sciences Limited and Sai Life Sciences Limited.

Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.